Stay updated on Bristol Myers Squibb Press Releases

Sign up to get notified when there's something new on the Bristol Myers Squibb Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Bristol Myers Squibb Press Releases page

  1. Check
    yesterday
    Change Detected
    Summary
    Added a March 9, 2026 press release detailing positive Phase 3 results for the SUCCESSOR-2 study of oral mezigdomide in relapsed or refractory multiple myeloma. Removed a February 3, 2026 marketing tagline 'Change the Target. Change What’s Possible.' highlighting unmet needs in cardiovascular and thromboembolic care.
    Difference
    9%
    Check dated 2026-03-16T00:30:38.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Added March 06, 2026: FDA approves Sotyktu for active Psoriatic Arthritis; March 02, 2026: Dividend announcement. Removed January 2026 items: collaboration with Microsoft on AI-driven lung cancer detection, Philanthropy News, and the Foundation's mental health initiatives program.
    Difference
    11%
    Check dated 2026-03-08T22:20:33.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    New press releases for February 2026 have been added and several 2025 items removed from the list. This updates the core content to reflect the latest announcements and maintain current recency.
    Difference
    11%
    Check dated 2026-03-01T14:31:36.000Z thumbnail image
  4. Check
    113 days ago
    Change Detected
    Summary
    Added two November 2025 press releases: 'Bristol Myers Squibb Announces Accepted Amounts and Pricing Terms of its Tender Offers' (Nov 18, 2025) and 'Bristol Myers Squibb Announces Early Participation Results, Amendment and Early Settlement of Tender Offers' (Nov 17, 2025). Removed older items from October 2025, including the SystImmune/BMS Phase I results from ESMO 2025 and philanthropy-related news such as the Bristol Myers Squibb Foundation donation announcement.
    Difference
    9%
    Check dated 2025-11-23T07:26:15.000Z thumbnail image
  5. Check
    121 days ago
    Change Detected
    Summary
    Added two new press releases: 'Update on Phase 3 Librexia ACS Trial' (Nov 14, 2025) and 'Sarah Cannon Research Institute and Bristol Myers Squibb Expand Strategic Collaboration to Accelerate Patient Enrollment and Broaden Access to Innovative Cancer Research' (Nov 12, 2025). Removed two older items: 'Bristol Myers Squibb to Present Data at ESMO 2025 Showcasing Progress of Oncology Portfolio Across Diverse Tumor Types' (Oct 13, 2025) and 'Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbital Therapeutics' (Oct 10, 2025).
    Difference
    9%
    Check dated 2025-11-16T05:13:56.000Z thumbnail image
  6. Check
    128 days ago
    Change Detected
    Summary
    New items add debt pricing and data/tender-offer announcements, while several regulatory and program updates are removed. Overall, the list of recent press releases shown on the Bristol Myers Squibb page changes significantly.
    Difference
    8%
    Check dated 2025-11-09T00:13:25.000Z thumbnail image

Stay in the know with updates to Bristol Myers Squibb Press Releases

Enter your email address, and we'll notify you when there's something new on the Bristol Myers Squibb Press Releases page.